These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 25728500)

  • 21. CRISPR-Cas3 Adds a Power Saw to the Toolbox for Human Genome Engineering.
    Hatoum-Aslan A
    CRISPR J; 2019 Jun; 2():150-152. PubMed ID: 31225749
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of RNA-guided technologies for target identification and deconvolution.
    Fennell M; Xiang Q; Hwang A; Chen C; Huang CH; Chen CC; Pelossof R; Garippa RJ
    J Biomol Screen; 2014 Dec; 19(10):1327-37. PubMed ID: 25163683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 and TALE: beyond cut and paste.
    Deng L; Ren R; Wu J; Suzuki K; Izpisua Belmote JC; Liu GH
    Protein Cell; 2015 Mar; 6(3):157-159. PubMed ID: 25722052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution mapping of cancer cell networks using co-functional interactions.
    Boyle EA; Pritchard JK; Greenleaf WJ
    Mol Syst Biol; 2018 Dec; 14(12):e8594. PubMed ID: 30573688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of CRISPR technologies in transplantation.
    Kuscu C; Kuscu C; Bajwa A; Eason JD; Maluf D; Mas VR
    Am J Transplant; 2020 Dec; 20(12):3285-3293. PubMed ID: 32484284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
    Kampmann M
    ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi screening comes of age: improved techniques and complementary approaches.
    Mohr SE; Smith JA; Shamu CE; Neumüller RA; Perrimon N
    Nat Rev Mol Cell Biol; 2014 Sep; 15(9):591-600. PubMed ID: 25145850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The societal opportunities and challenges of genome editing.
    Carroll D; Charo RA
    Genome Biol; 2015 Nov; 16():242. PubMed ID: 26537374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancements in CRISPR screens for the development of cancer immunotherapy strategies.
    Li YR; Lyu Z; Tian Y; Fang Y; Zhu Y; Chen Y; Yang L
    Mol Ther Oncolytics; 2023 Dec; 31():100733. PubMed ID: 37876793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility metrics for context-specific CRISPR screens.
    Billmann M; Ward HN; Aregger M; Costanzo M; Andrews BJ; Boone C; Moffat J; Myers CL
    Cell Syst; 2023 May; 14(5):418-422.e2. PubMed ID: 37201508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Perturb-seq enables genome-scale genetic screens in single cells.
    Schraivogel D; Gschwind AR; Milbank JH; Leonce DR; Jakob P; Mathur L; Korbel JO; Merten CA; Velten L; Steinmetz LM
    Nat Methods; 2020 Jun; 17(6):629-635. PubMed ID: 32483332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlocking biological mechanisms with integrative functional genomics approaches.
    Yun S; Noh M; Yu J; Kim HJ; Hui CC; Lee H; Son JE
    Mol Cells; 2024 Aug; 47(8):100092. PubMed ID: 39019219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward a CRISPR understanding of gene function in human brain development.
    Li E; Kampmann M
    Cell Stem Cell; 2023 Dec; 30(12):1561-1562. PubMed ID: 38065064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
    Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
    Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Current Situation and Development Prospect of Whole-Genome Screening.
    Yang C; Lei Y; Ren T; Yao M
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pooled screening with next-generation gene editing tools.
    Zhou L; Yang L; Feng Y; Chen S
    Curr Opin Biomed Eng; 2023 Dec; 28():. PubMed ID: 38222973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR knockout screen implicates three genes in lysosome function.
    Lenk GM; Park YN; Lemons R; Flynn E; Plank M; Frei CM; Davis MJ; Gregorka B; Swanson JA; Meisler MH; Kitzman JO
    Sci Rep; 2019 Jul; 9(1):9609. PubMed ID: 31270356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens.
    Mattson NM; Chan AKN; Miyashita K; Mukhaleva E; Chang WH; Yang L; Ma N; Wang Y; Pokharel SP; Li M; Liu Q; Xu X; Chen R; Singh P; Zhang L; Elsayed Z; Chen B; Keen D; Pirrotte P; Rosen ST; Chen J; LaBarge MA; Shively JE; Vaidehi N; Rockne RC; Feng M; Chen CW
    Nat Struct Mol Biol; 2024 Mar; 31(3):465-475. PubMed ID: 38316881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a comprehensive catalogue of validated and target-linked human enhancers.
    Gasperini M; Tome JM; Shendure J
    Nat Rev Genet; 2020 May; 21(5):292-310. PubMed ID: 31988385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massively Parallel Reporter Assays: Defining Functional Psychiatric Genetic Variants Across Biological Contexts.
    Mulvey B; Lagunas T; Dougherty JD
    Biol Psychiatry; 2021 Jan; 89(1):76-89. PubMed ID: 32843144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.